Shares of Surrozen, Inc. (NASDAQ:SRZN – Get Free Report) traded up 4.3% during trading on Tuesday . The company traded as high as $10.38 and last traded at $9.78. 41,869 shares changed hands during trading, an increase of 214% from the average session volume of 13,335 shares. The stock had previously closed at $9.38.
Surrozen Stock Performance
The business’s 50 day moving average is $9.59 and its 200 day moving average is $9.69.
Surrozen (NASDAQ:SRZN – Get Free Report) last issued its earnings results on Monday, August 12th. The company reported ($1.54) EPS for the quarter, topping analysts’ consensus estimates of ($2.79) by $1.25. Analysts expect that Surrozen, Inc. will post -9.49 EPS for the current year.
Institutional Investors Weigh In On Surrozen
Surrozen Company Profile
Surrozen, Inc, a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.
Featured Stories
- Five stocks we like better than Surrozen
- Where Do I Find 52-Week Highs and Lows?
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- How to Use the MarketBeat Excel Dividend Calculator
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Surrozen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surrozen and related companies with MarketBeat.com's FREE daily email newsletter.